{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T17:00:53Z","timestamp":1756573253663},"reference-count":19,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3960\/jslrt.54.225","type":"journal-article","created":{"date-parts":[[2014,12,14]],"date-time":"2014-12-14T23:18:21Z","timestamp":1418599101000},"page":"225-235","source":"Crossref","is-referenced-by-count":8,"title":["Variant Translocation Partners of the Anaplastic Lymphoma Kinase (ALK) Gene in Two Cases of Anaplastic Large Cell Lymphoma, Identified by Inverse cDNA Polymerase Chain Reaction"],"prefix":"10.3960","volume":"54","author":[{"given":"Kayo","family":"Takeoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen","family":"Honjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Stein H, Foss HD, D\u00fcrkop H, Marafioti T, Delsol G, <i>et al<\/i>.: CD30<sup>+<\/sup> anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood 96:3681-3695, 2000"},{"key":"2","unstructured":"2 Delsol G, Jaffe ES, Falini B, Gascoyne RD, M\u00fcller-Hermelink HK, <i>et al<\/i>.: Anaplastic large cell lymphoma (ALCL), ALK-positive. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, <i>et al<\/i>. (eds): World Health Organization Classification of Tumours, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, International Agency for Research on Cancer (IARC), pp.312-316, 2008"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Chiarle R, Voena C, Ambrogio C, Piva R, Inghirami G: The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer 8:11-23, 2008","DOI":"10.1038\/nrc2291"},{"key":"4","unstructured":"4 Trinei M, Lanfrancone L, Campo E, Pulford K, Mason DY, <i>et al<\/i>.: A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma. Cancer Res 60:793-798, 2000"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Feldman AL, Vasmatzis G, Asmann YW, Davila J, Middha S, <i>et al<\/i>.: Novel <i>TRAF1<\/i>-<i>ALK<\/i> fusion identified by deep RNA sequencing of anaplastic large cell lymphoma. Genes Chromosomes Cancer 52:1097-1102, 2013","DOI":"10.1002\/gcc.22104"},{"key":"6","unstructured":"6 ISCN (2009): An International System for Human Cytogenetic Nomenclature (2009). Basel, S. Karger, 2009"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Takeuchi K, Choi YL, Togashi Y, Soda M, Hatano S, <i>et al<\/i>.: KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer. Clin Cancer Res 15:3143-3149, 2009","DOI":"10.1158\/1078-0432.CCR-08-3248"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ma Z, Cools J, Marynen P, Cui X, Siebert R, <i>et al<\/i>.: Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. Blood 95:2144-2149, 2000","DOI":"10.1182\/blood.V95.6.2144"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Dirks WG, F\u00e4hnrich S, Lis Y, Becker E, MacLeod RA, <i>et al<\/i>.: Expression and functional analysis of the anaplastic lymphoma kinase (<i>ALK<\/i>) gene in tumor cell lines. Int J Cancer 100:49-56, 2002","DOI":"10.1002\/ijc.10435"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Allouche M: ALK (anaplastic lymphoma receptor tyrosine kinase). Atlas Genet Cytogenet Oncol Haematol. February 2010. URL: http:\/\/AtlasGeneticsOncology.org\/Genes\/ALK.html, 2010","DOI":"10.4267\/2042\/44894"},{"key":"11","unstructured":"11 Akasaka H, Akasaka T, Kurata M, Ueda C, Shimizu A, <i>et al<\/i>.: Molecular anatomy of <i>BCL6<\/i> translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res 60:2335-2341, 2000"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Wlodarska I, De Wolf-Peeters C, Falini B, Verhoef G, Morris SW, <i>et al<\/i>.: The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of <i>ALK<\/i>-positive anaplastic large-cell lymphoma. Blood 92:2688-2695, 1998","DOI":"10.1182\/blood.V92.8.2688.420a42_2688_2695"},{"key":"13","unstructured":"13 Okamori S, Maesako Y, Ehara J, Fujita K, Takeoka K, <i>et al<\/i>.: An elderly man with anaplastic large cell lymphoma carrying inv(2)(p23q35) who presented with cardiopulmonary failure: Clinical, pathological, and cytogenetic features and postmortem findings. Tenri Medical Bulletin 16:89-100, 2013"},{"key":"14","unstructured":"14 TRAF1 TNF receptor-associated factor 1 [<i>Homo sapiens<\/i> (human)]. Available at: http:\/\/www.ncbi.nlm.nih.gov\/gene\/7185"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Rothe M, Wong SC, Henzel WJ, Goeddel DV: A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78:681-692, 1994","DOI":"10.1016\/0092-8674(94)90532-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Chung JY, Park YC, Ye H, Wu H: All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 115:679-688, 2002","DOI":"10.1242\/jcs.115.4.679"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Sibon D, Fournier M, Briere J, Lamant L, Haioun C, <i>et al<\/i>.: Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d&apos;Etude des Lymphomes de l&apos;Adulte trials. J Clin Oncol 30:3939-3946, 2012","DOI":"10.1200\/JCO.2012.42.2345"},{"key":"18","unstructured":"18 Matsubara K, Tanaka T, Taki T, Nakagawa A, Nigami H, <i>et al<\/i>.: <i>ATIC<\/i>-<i>ALK<\/i>-positive anaplastic large cell lymphoma: a case report and review of the literature. Rinsho Ketsueki 49:325-330, 2008 (<i>in Japanese<\/i>)"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Maesako Y, Izumi K, Okamori S, Takeoka K, Kishimori C, <i>et al<\/i>.: inv(2)(p23q13)\/RAN-binding protein 2 (<i>RANBP2<\/i>)-<i>ALK<\/i> fusion gene in myeloid leukemia that developed in an elderly woman. Int J Hematol 99:202-207, 2014","DOI":"10.1007\/s12185-013-1482-x"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T11:19:39Z","timestamp":1650799179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/54\/3\/54_225\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.54.225","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}